363 related articles for article (PubMed ID: 30972872)
1. Biologics for psoriasis: What is new?
Özyurt K; Ertaş R; Atasoy M
Dermatol Ther; 2019 May; 32(3):e12916. PubMed ID: 30972872
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis.
Kirkham BW; Kavanaugh A; Reich K
Immunology; 2014 Feb; 141(2):133-42. PubMed ID: 23819583
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of psoriasis and development of treatment.
Ogawa E; Sato Y; Minagawa A; Okuyama R
J Dermatol; 2018 Mar; 45(3):264-272. PubMed ID: 29226422
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
[TBL] [Abstract][Full Text] [Related]
5. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
Blauvelt A; Chiricozzi A
Clin Rev Allergy Immunol; 2018 Dec; 55(3):379-390. PubMed ID: 30109481
[TBL] [Abstract][Full Text] [Related]
6. New biologics for psoriasis and psoriatic arthritis.
Rozenblit M; Lebwohl M
Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis and the TNF/IL23/IL17 axis.
Furue K; Ito T; Tsuji G; Kadono T; Furue M
G Ital Dermatol Venereol; 2019 Aug; 154(4):418-424. PubMed ID: 30648836
[TBL] [Abstract][Full Text] [Related]
8. New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection.
Ceccarelli M; Venanzi Rullo E; Berretta M; Cacopardo B; Pellicanò GF; Nunnari G; Guarneri C
Dermatol Ther; 2021 Jan; 34(1):e14660. PubMed ID: 33301216
[TBL] [Abstract][Full Text] [Related]
9. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
10. Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis.
Victor FC; Gottlieb AB; Menter A
Clin Dermatol; 2003; 21(5):392-7. PubMed ID: 14678719
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab.
Garcia-Valladares I; Cuchacovich R; Espinoza LR
Drug Des Devel Ther; 2011 Jan; 5():41-9. PubMed ID: 21267358
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
13. Immunopathogenesis of psoriasis and psoriatic arthritis and pharmacological perspectives.
Loffredo S; Ayala F; Marone GC; Genovese A; Marone G
Reumatismo; 2007; 59 Suppl 1():28-39. PubMed ID: 17828356
[TBL] [Abstract][Full Text] [Related]
14. Biologics and Psoriasis: The Beat Goes On.
Kim HJ; Lebwohl MG
Dermatol Clin; 2019 Jan; 37(1):29-36. PubMed ID: 30466686
[TBL] [Abstract][Full Text] [Related]
15. The TNF/IL-23/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment.
Ten Bergen LL; Petrovic A; Krogh Aarebrot A; Appel S
Scand J Immunol; 2020 Oct; 92(4):e12946. PubMed ID: 32697374
[TBL] [Abstract][Full Text] [Related]
16. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Lovato P; Norsgaard H; Tokura Y; Røpke MA
J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
[TBL] [Abstract][Full Text] [Related]
17. [Biologics. New drugs, new adverse reactions].
Prinz JC
Hautarzt; 2010 Aug; 61(8):668-75. PubMed ID: 20585746
[TBL] [Abstract][Full Text] [Related]
18. Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management.
Rodríguez-Cerdeira C; González-Cespón JL; Martínez-Herrera E; Carnero-Gregorio M; López-Barcenas A; Sergeev A; Saunte DM
Ital J Dermatol Venerol; 2021 Oct; 156(5):545-557. PubMed ID: 33026212
[TBL] [Abstract][Full Text] [Related]
19. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
Novelli L; Chimenti MS; Chiricozzi A; Perricone R
Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
[TBL] [Abstract][Full Text] [Related]
20. Secukinumab for treating plaque psoriasis.
Rothstein B; Gottlieb A
Expert Opin Biol Ther; 2016; 16(1):119-28. PubMed ID: 26577956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
